Research Topics
Genomes and Genes | Thierry CalandraSummaryAffiliation: Centre Hospitalier Universitaire Vaudois Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
The international sepsis forum consensus conference on definitions of infection in the intensive care unitThierry Calandra
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Crit Care Med 33:1538-48. 2005..Use of these definitions in clinical trials should help improve the quality of clinical research in this field...
Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseasesPascal Renner
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Clin Infect Dis 41:S513-9. 2005..Analyses of MIF genotypes in patients with sepsis may help to classify patients into risk categories and to identify those patients who may benefit from anti-MIF therapeutic strategies...
Clinical trials of antifungal prophylaxis among patients undergoing surgeryThierry Calandra
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Clin Infect Dis 39:S185-92. 2004..The aim is to maximize chances of reducing morbidity and mortality while minimizing treatment costs, exposure of low-risk patients to adverse events, and emergence of resistant fungal strains...
Macrophage migration inhibitory factor: a regulator of innate immunityThierry Calandra
Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH 1011 Lausanne, Switzerland
Nat Rev Immunol 3:791-800. 2003....
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylationJérôme Lugrin
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH 1011 Lausanne, Switzerland
Biochim Biophys Acta 1793:1749-58. 2009....
Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of Parachlamydia acanthamoebaeThierry Roger
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Infect Immun 78:5195-201. 2010..Thus, in contrast to Chlamydia pneumoniae, Parachlamydia acanthamoebae weakly stimulates macrophages, potentially compensating for its low replication capacity in macrophages by escaping the innate immune surveillance...
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomesAndres Pascual
Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Clin Infect Dis 46:201-11. 2008..Liver disease, age, genetic polymorphism of the cytochrome CYP2C19, and comedications influence voriconazole metabolism. Large variations in voriconazole pharmacokinetics may be associated with decreased efficacy or with toxicity...
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infectionsAndres Pascual
Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland
Clin Infect Dis 55:381-90. 2012..Recommended oral voriconazole (VRC) doses are lower than intravenous doses. Because plasma concentrations impact efficacy and safety of therapy, optimizing individual drug exposure may improve these outcomes...
Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expressionThierry Roger
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Eur J Immunol 37:3509-21. 2007....
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patientsLaurence Senn
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois CHUV and University of Lausanne UNIL, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Intensive Care Med 35:903-8. 2009..The aim of this study was to explore the efficacy and safety of caspofungin for prevention of intra-abdominal IC in high-risk surgical patients...
Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4Thierry Roger
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH 1011 Lausanne, Switzerland
Proc Natl Acad Sci U S A 106:2348-52. 2009..coli sepsis when administered in a prophylactic and therapeutic manner up to 13 h after the onset of bacterial sepsis. These experimental data provide strong support for the concept of TLR4-targeted therapy for gram-negative sepsis...
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infectionThierry Roger
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 46, Lausanne, Switzerland
Blood 117:1205-17. 2011..Thus, these data identify an essential role for HDAC inhibitors in the regulation of the expression of innate immune genes and host defenses against microbial pathogens...
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemiaLaurence Senn
Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Clin Infect Dis 46:878-85. 2008..The aim of the present prospective study was to evaluate the usefulness of monitoring BG in patients undergoing chemotherapy for acute leukemia...
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsisThierry Roger
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland
J Infect Dis 207:331-9. 2013..Together, these data show that MIF is a key mediator of host responses against gram-negative bacteria, acting in part via a modulation of bacterial killing by macrophages...
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infectionJulie Delaloye
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Cytokine 60:338-40. 2012..Our results suggest that MIF is an integral component of the cytokine storm characteristic of AHI...
Histone deacetylase inhibitors impair antibacterial defenses of macrophagesMatteo Mombelli
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland
J Infect Dis 204:1367-74. 2011..These data indicate that HDACi have a strong impact on critical antimicrobial defense mechanisms in macrophages...
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal diseasePascal Renner
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
FASEB J 26:907-16. 2012..09 and P=0.09 for MIF production). Taken together, these data suggest that polymorphisms of the MIF gene affecting MIF expression are associated with the occurrence, severity, and outcome of meningococcal disease in children...
Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newbornsEric Giannoni
Service of Neonatology, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Infect Immun 79:2690-8. 2011..Therefore, intrauterine exposure to estradiol and progesterone may participate in increasing susceptibility to infection during the neonatal period...
Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)Thierry Roger
Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
J Endotoxin Res 9:119-23. 2003..These findings identify an important role for MIF in innate immunity and provide a rationale for the development of anti-MIF strategy for the treatment of patients with Gram-negative septic shock...
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspoLaurent Arthur Decosterd
Division of Clinical Pharmacology, Department of Medicine, BH18, Lab 218 226, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH 1011 Lausanne, Switzerland
Antimicrob Agents Chemother 54:5303-15. 2010....
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsisThierry Calandra
Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
J Infect Dis 187:S385-90. 2003..Given its role in innate immune responses to bacterial infections, MIF is a novel target for therapeutic intervention in patients with septic shock...
Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1Thierry Roger
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Eur J Immunol 35:3405-13. 2005..Taken together, these data identify MKP-1 as a molecular target of MIF-glucocorticoid crosstalk and provide a molecular basis for the control of macrophage responses by a pair of physiological regulators of innate immunity...
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeJulie Delaloye
Department of Medicine, Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
PLoS Pathog 5:e1000480. 2009..Delineation of the host response induced by MVA is critical for improving our understanding of poxvirus antiviral escape mechanisms and for designing new MVA vaccine vectors with improved immunogenicity...
Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?James Owen Robinson
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne UNIL, Lausanne, Switzerland
PLoS ONE 6:e18886. 2011..We aimed at evaluating the utility of monitoring blood procalcitonin (PCT) in FE for initial diagnosis of infection and reassessment in persistent fever...
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methodsAndres Pascual
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH 1011 Lausanne, Switzerland
Antimicrob Agents Chemother 51:137-43. 2007..Simple HPLC and bioassay methods offer new tools for monitoring voriconazole therapy...
Bench-to-bedside review: Candida infections in the intensive care unitMarie Méan
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland
Crit Care 12:204. 2008..These include lipid formulations of amphotericin B, new azoles (voriconazole and posaconazole) and echinocandins (caspofungin, micafungin and anidulafungin)...
Histoplasma capsulatum var. duboisii infection in a patient with AIDS: rapid diagnosis using polymerase chain reaction-sequencingCyril Pellaton
Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
Diagn Microbiol Infect Dis 64:85-9. 2009..The variety duboisii of Hc was established using DNA sequencing of the polymorphic genomic region OLE. Molecular tools allow diagnosis of histoplasmosis in 24 h, which is drastically shorter than culture procedures...
Liquid chromatography-mass spectrometry method for quantification of caspofungin in clinical plasma samplesBertrand Rochat
Quantitative Mass Spectrometry Facility, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
J Mass Spectrom 42:440-9. 2007..Mean intra- and inter-day precision was 7.9 +/- 3.2% and 6.3 +/- 1.8%, respectively. This simple and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method may easily be implemented for monitoring CASPO therapy...
Candida arteritis in patients who have not received organ transplants: case report and review of the literatureCaroline Chapuis-Taillard
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Clin Infect Dis 46:e106-11. 2008..A high index of suspicion, early diagnosis, and prompt antifungal and surgical treatment seem crucial to efforts to avoid life-threatening arterial rupture and hemorrhage...
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active diseaseAlexandre Harari
Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
Nat Med 17:372-6. 2011..4%. Therefore, the proportion of single-positive TNF-α Mtb-specific CD4+ T cells is a new tool for the rapid diagnosis of active tuberculosis disease...
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodiesMaura Prella
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland
Diagn Microbiol Infect Dis 51:95-101. 2005..001). Candidiasis was diagnosed before neutrophil recovery in 78% and 11% of cases with Mn/anti-Mn and radiology, respectively (P < 0.001). Mn and anti-Mn may be useful for early noninvasive diagnosis of IC...
Changing face of health-care associated fungal infectionsJacques Bille
Institute of Microbiology, Centre Hospitalier Universitaire Vaudois, CH 1011 Lausanne, Switzerland
Curr Opin Infect Dis 18:314-9. 2005..The purpose of this review was to evaluate recent publications on the epidemiology, diagnosis and management of invasive fungal infections...
[New therapeutic strategies in severe sepsis and septic shock]Mauro Oddo
Division des soins intensifs, Departement de Medecine, Interne CHUV, Lausanne
Rev Med Suisse Romande 124:329-32. 2004..This review will focus on these recently acquired therapeutic modalities, that are presently available to clinicians for the treatment of severe sepsis and septic shock...
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expressionThierry Roger
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, BH19 111, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland
Biochem J 387:355-65. 2005..Yet, notable differences exist with respect to the elements implicated in gene regulation, which may account for species differences in terms of tissue expression and modulation by microbial and inflammatory stimuli...
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patientsOriol Manuel
Transplantation Center, Infectious Diseases Service, University Hospital of Lausanne CHUV and University of Lausanne, Switzerland
Clin Infect Dis 52:248-56. 2011..We evaluated the humoral response to the influenza A H1N1/09 vaccine in solid-organ transplant (SOT) recipients, in patients with human immunodeficiency virus (HIV) infection, and in healthy individuals...
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000Oscar Marchetti
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Clin Infect Dis 38:311-20. 2004..krusei remained rare (2%). Fluconazole consumption increased significantly (P<.001). Despite increasing high-risk activities, the incidence of candidemia remained unchanged, and no shift to resistant species occurred...
Macrophage migration inhibitory factor and host innate immune responses to microbesThierry Calandra
Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Scand J Infect Dis 35:573-6. 2003..Given that it is a pivotal regulator of innate immune responses to bacterial infections, MIF appears to be a perfect target for novel therapeutic interventions in patients with severe sepsis...
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophagesMauro Oddo
Medical Critical Care Division, University Hospital, CH 1011 Lausanne, Switzerland
Infect Immun 73:3783-6. 2005..Its role in immunity to intracellular pathogens has not been well studied. Here, we show that MIF released by infected human macrophages inhibits the growth of virulent Mycobacterium tuberculosis...
Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella speciesLaurence Senn
Infectious Diseases Service, University Hospital, Lausanne, Switzerland
BMC Infect Dis 6:9. 2006..In this study, we reviewed the clinical manifestations of infections due to A. defectiva and Granulicatella species that occurred at our institution between 1998 and 2004...
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cellsThomas Tawadros
Service of Urology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 46, Lausanne, Switzerland
Endocr Relat Cancer 20:137-49. 2013..Thus, MIF could represent an attractive target for PCa therapy...
Host innate immune responses to microbial pathogensJulie Delaloye
Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
Curr Vasc Pharmacol 11:123-32. 2013..Important components of the puzzle have already been identified, but the hunt must go on in the laboratory and at the bedside...
Cytokines in septic shockThierry Calandra
Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Curr Clin Top Infect Dis 22:1-23. 2002
Infections in neutropenic cancer patientsOscar Marchetti
Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Lancet 359:723-5. 2002
Pathogenesis of sepsis: new concepts and implications for future treatmentPierre-Yves Bochud
Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103-8904, USA
BMJ 326:262-6. 2003
Antifungal prophylaxis for intensive care unit patients: let's fine tune itThierry Calandra
Intensive Care Med 28:1698-1700. 2002
Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"Thierry Calandra
Intensive Care Med 29:1196. 2003
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger
Cooper University Hospital, Camden, NJ, USA
Crit Care Med 36:296-327. 2008..To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock," published in 2004...
Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based reviewPierre-Yves Bochud
The Institute for Systems Biology, Seattle, WA, USA
Crit Care Med 32:S495-512. 2004..However, to minimize the promotion of antimicrobial resistance and cost and to maximize efficacy, detailed knowledge of the likely pathogens and the properties of the available drugs is necessary for the intensivist...
Treatment options of invasive fungal infections in adultsUrsula Fluckiger
Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Basel, Switzerland
Swiss Med Wkly 136:447-63. 2006..Amphotericin B deoxycholate is recommended as initial therapy for the empirical therapy in patients with neutropenia and persistent fever with close monitoring of adverse events...
Sepsis: time to reconsider the conceptJean Carlet
Intensive Care Unit, Infectious Diseases Department, Groupe Hospitalier Paris Saint Joseph, Paris, France
Crit Care Med 36:964-6. 2008..To discuss the difficulty in using the concept of sepsis for clinical trials and propose new ways for designing future trials for severe infections...
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factorTimothy R D J Radstake
Department of Rheumatology, Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Arthritis Rheum 52:3020-9. 2005..To study whether genetic variants of macrophage migration inhibitory factor (MIF), the MIF -173G>C and CATT(5-8) alleles, are associated with disease severity and levels of circulating MIF in patients with rheumatoid arthritis (RA)...
Invasive candidiasis: comparison of management choices by infectious disease and critical care specialistsPhilippe Eggimann
Infection Control Program, University of Geneva Hospitals, 24 rue Micheli-du-Crest, 1211, Geneva 14, Switzerland
Intensive Care Med 31:1514-21. 2005..1% vs. 51%). CONCLUSIONS: These data highlight differences between management approaches for candidiasis in two groups of specialists, particularly in the reported use of antifungals...
The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunityHarry Flaster
Yale University School of Medicine, New Haven, Connecticut 06520, USA
Mol Endocrinol 21:1267-80. 2007..Therapeutic antagonism of MIF may be an effective approach for steroid-sparing therapies in patients with refractory autoimmune or inflammatory diseases...
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemiaTom Sprong
Department of General Internal Medicine, The Nijmegen University Centre for Infectious Diseases, Nijmegen, The Netherlands
Shock 27:482-7. 2007..Macrophage migration inhibitory factor cannot be detected in a human endotoxemia model and is not produced by whole blood cells incubated with LPS or meningococci...
MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritisCalin Popa
Department of Rheumatology, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
Cytokine 36:51-6. 2006..The secretion of MIF by dendritic cells is differentially regulated by TLRs. In addition, TNF-alpha, RANKL, and CD40L augment MIF production by DCs and thus play a potential role in the amplification of the inflammatory loop in RA...
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in diseaseHongqi Lue
Laboratory of Biochemistry, Institute for Interfacial Engineering, University of Stuttgart, 70569 Stuttgart, Germany
Microbes Infect 4:449-60. 2002..Its mechanism of action is incompletely understood. Here, we attempt to correlate current knowledge on the molecular pathways of MIF activity with its functions in immunity and disease...
Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery diseaseMartijn Kwaijtaal
Department of Medical Microbiology, University Hospital Maastricht, P Debeyeplein 25, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
Psychosom Med 69:68-73. 2007..The first origin of MIF suggests positive, the second negative associations. The aim of this study was to explore the direction of the association of MIF with CAD and of MIF with exhaustion, if any...
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsisMarieke Emonts
Department of Pediatrics, Erasmus MC Sophia Children s Hospital University Medical Center, Rotterdam, The Netherlands
Clin Infect Dis 44:1321-8. 2007....
Innate immunogenetics: a tool for exploring new frontiers of host defencePierre Yves Bochud
Institute for Systems Biology, Seattle, WA, USA
Lancet Infect Dis 7:531-42. 2007..This is likely to open new perspectives for the development of diagnostic, predictive, and preventive management strategies to combat infectious diseases...
Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factorBeatriz E Rendon
Molecular Targets Program, J G Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA
J Biol Chem 282:29910-8. 2007....
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockR Phillip Dellinger
Section of Critical Care Medicine, Cooper University Hospital, One Cooper Plaza, 393 Dorrance, Camden, NJ 08103, USA
Intensive Care Med 30:536-55. 2004..The impact of these guidelines will be formally tested and guidelines updated annually, and even more rapidly when some important new knowledge becomes available...
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockR Phillip Dellinger
Crit Care Med 32:858-73. 2004..The impact of these guidelines will be formally tested and guidelines updated annually and even more rapidly as some important new knowledge becomes as available...
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activityHongqi Lue
Department of Biochemistry and Molecular Cell Biology, Institute of Biochemistry, University Hospital of the RWTH Aachen, Pauwelsstrasse 30, D 52074 Aachen, Germany
Cell Signal 18:688-703. 2006....
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger
Cooper University Hospital, One Cooper Plaza, 393 Dorrance, Camden 08103, NJ, USA
Intensive Care Med 34:17-60. 2008..To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock," published in 2004...
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseasesGibson S Kibiki
Department of Internal Medicine, Endoscopy Unit, KCMC, Tumaini University, P O Box 3010, Moshi, Tanzania
Clin Immunol 123:60-5. 2007..In conclusion, HIV infection was associated with elevated serum MIF levels regardless of PTB. Low serum MIF levels were associated with high mortality...
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis ForumJohn C Marshall
Department of Surgery, Interdepartmental Division of Critical Care Medicine, University of Toronto, St Michael s Hospital, Canada
Crit Care Med 33:1708-16. 2005..We sought to evaluate existing approaches and to draw on insights from other disciplines to propose a comprehensive approach to outcome evaluation in sepsis clinical trials...
A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancerMurat Akova
Section of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey
Clin Infect Dis 40:239-45. 2005..Neutropenic patients with cancer may develop several episodes of fever and infection during chemotherapy-induced myeloaplasia...
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) CBen de Pauw
Department of Blood Transfusion Service and Transplant Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Clin Infect Dis 46:1813-21. 2008..Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies...
